Burkitt Lymphoma: Relapsed/Refractory

The term “relapsed” refers to disease that reappears or grows again after a period of remission.

The term “refractory” is used to describe when the lymphoma does not respond to treatment (meaning that the cancer cells continue to grow) or when the response to treatment does not last very long.

Central Nervous System (CNS) involvement at diagnosis of Burkitt lymphoma is recognized as the strongest risk factor for relapse; therefore, recommended treatment regimens include treatment to protect the CNS, which may be given intrathecally (injected into the spinal fluid).

To learn more about primary central nervous system (CNS) lymphoma, visit the CNS Lymphoma page.

See Also:

• Download the Burkitt Lymphoma Fact Sheet